These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


396 related items for PubMed ID: 25887085

  • 21. Progress Toward Rubella Elimination - World Health Organization European Region, 2005-2019.
    O'Connor P, Jankovic D, Zimmerman L, Ben Mamou M, Reef S.
    MMWR Morb Mortal Wkly Rep; 2021 Jun 11; 70(23):833-839. PubMed ID: 34111057
    [Abstract] [Full Text] [Related]

  • 22. Epidemiological surveillance and control of rubella in Singapore, 1991-2007.
    Ang LW, Chua LT, James L, Goh KT.
    Ann Acad Med Singap; 2010 Feb 11; 39(2):95-101. PubMed ID: 20237729
    [Abstract] [Full Text] [Related]

  • 23. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008.
    Lacapère F, Magloire R, Danovaro-Holliday MC, Flannery B, Chamoulliet H, Celestin EP.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S698-705. PubMed ID: 21954269
    [Abstract] [Full Text] [Related]

  • 24. Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience.
    Morice A, Carvajal X, León M, Machado V, Badilla X, Reef S, Lievano F, Depetris A, Castillo-Solórzano C.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S158-63. PubMed ID: 12721908
    [Abstract] [Full Text] [Related]

  • 25. Progress towards measles and rubella elimination in Tuscany, Italy: the role of population seroepidemiological profile.
    Bechini A, Boccalini S, Tiscione E, Pesavento G, Mannelli F, Peruzzi M, Rapi S, Mercurio S, Bonanni P.
    Eur J Public Health; 2012 Feb 15; 22(1):133-9. PubMed ID: 20880991
    [Abstract] [Full Text] [Related]

  • 26. Congenital rubella syndrome: a matter of concern.
    Martínez-Quintana E, Castillo-Solórzano C, Torner N, Rodríguez-González F.
    Rev Panam Salud Publica; 2015 Mar 15; 37(3):179-86. PubMed ID: 25988255
    [Abstract] [Full Text] [Related]

  • 27. Rubella elimination programme strengthened through measles elimination programme in Catalonia.
    Domínguez A, Torner N, Martínez A, Costa J, Plans P, Ciruela P, Salleras L.
    Vaccine; 2006 Feb 27; 24(9):1433-7. PubMed ID: 16226357
    [Abstract] [Full Text] [Related]

  • 28. Global Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - 2000-2014.
    Grant GB, Reef SE, Dabbagh A, Gacic-Dobo M, Strebel PM.
    MMWR Morb Mortal Wkly Rep; 2015 Sep 25; 64(37):1052-5. PubMed ID: 26401958
    [Abstract] [Full Text] [Related]

  • 29. Towards elimination of measles and rubella in Italy: Progress and challenges.
    Adamo G, Baccolini V, Massimi A, Barbato D, Cocchiara R, Di Paolo C, Mele A, Cianfanelli S, Angelozzi A, Castellani F, Salerno C, Isonne C, Bella A, Filia A, Del Manso M, Baggieri M, Nicoletti L, Magurano F, Iannazzo S, Marzuillo C, Villari P.
    PLoS One; 2019 Sep 25; 14(12):e0226513. PubMed ID: 31841530
    [Abstract] [Full Text] [Related]

  • 30. Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine.
    Riddell M, Senn N, Clements CJ, Hobday L, Cowie B, Kurubi J, Kevin A, Siba P, Reeder JC, Morgan C.
    Vaccine; 2012 Dec 14; 30(52):7506-12. PubMed ID: 23103194
    [Abstract] [Full Text] [Related]

  • 31. Seroprevalence of measles and rubella virus antibodies in the population of the Community of Madrid, 2008-2009.
    García-Comas L, Sanz Moreno JC, Ordobás Gavín M, Barranco Ordóñez D, García Gutiérrez J, Ramos Blázquez B, Rodero Garduño I.
    J Infect Public Health; 2015 Dec 14; 8(5):432-40. PubMed ID: 25957894
    [Abstract] [Full Text] [Related]

  • 32. Toward rubella elimination in Europe: an epidemiological assessment.
    Muscat M, Zimmerman L, Bacci S, Bang H, Glismann S, Mølbak K, Reef S, EUVAC.NET group.
    Vaccine; 2012 Mar 02; 30(11):1999-2007. PubMed ID: 22178098
    [Abstract] [Full Text] [Related]

  • 33. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
    Hayford K, Mutembo S, Carcelen A, Matakala HK, Munachoonga P, Winter A, Wanyiri JW, Searle K, Mwansa FD, Mwiche A, Phiri C, Book C, Thuma PE, Moss WJ.
    Vaccine; 2019 Apr 17; 37(17):2387-2393. PubMed ID: 30905529
    [Abstract] [Full Text] [Related]

  • 34. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I, Kontio M, Paunio M, Peltola H.
    Expert Rev Vaccines; 2010 Sep 17; 9(9):1045-53. PubMed ID: 20822347
    [Abstract] [Full Text] [Related]

  • 35. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.
    Theeten H, Hutse V, Hens N, Yavuz Y, Hoppenbrouwers K, Beutels P, Vranckx R, Van Damme P.
    Epidemiol Infect; 2011 Apr 17; 139(4):494-504. PubMed ID: 20587123
    [Abstract] [Full Text] [Related]

  • 36. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R, Rahman MM, Hassan Z, Hassan MS.
    Scand J Immunol; 2006 Dec 17; 64(6):684-9. PubMed ID: 17083626
    [Abstract] [Full Text] [Related]

  • 37. Progress Toward Rubella and Congenital Rubella Syndrome Control - South-East Asia Region, 2000-2016.
    Khanal S, Bahl S, Sharifuzzaman M, Dhongde D, Pattamadilok S, Reef S, Morales M, Dabbagh A, Kretsinger K, Patel M.
    MMWR Morb Mortal Wkly Rep; 2018 Jun 01; 67(21):602-606. PubMed ID: 29851943
    [Abstract] [Full Text] [Related]

  • 38. Epidemiology of measles, mumps and rubella in Italy.
    Gabutti G, Rota MC, Salmaso S, Bruzzone BM, Bella A, Crovari P, Serological Study Group.
    Epidemiol Infect; 2002 Dec 01; 129(3):543-50. PubMed ID: 12558337
    [Abstract] [Full Text] [Related]

  • 39. Rubella seroprofile of the Italian population: an 8-year comparison.
    Rota MC, Bella A, Gabutti G, Giambi C, Filia A, Guido M, De Donno A, Crovari P, Ciofi Degli Atti ML, Serological Study Group.
    Epidemiol Infect; 2007 May 01; 135(4):555-62. PubMed ID: 17076939
    [Abstract] [Full Text] [Related]

  • 40. Approach to verify the status of measles, rubella, and congenital rubella syndrome elimination in Costa Rica.
    Morice A, Avila-Aguero ML, Salas-Peraza D, Soriano A, Castillo-Solórzano C.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S690-7. PubMed ID: 21954268
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 20.